Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? [PDF]
Mark Richards +4 more
openalex +1 more source
Quantitative Three-dimensional Scanning of Facial Movements in Facioscapulohumeral Dystrophy
Background: Facioscapulohumeral dystrophy (FSHD) is the third prevalent neuromuscular disorder, particularly with facial and upper limb involvement. Due to its characteristics, quantitative assessment of facial function is challenging but essential for ...
Ceren Hangul +6 more
doaj +1 more source
If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD) [PDF]
James E. Hilbert +8 more
openalex +1 more source
Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2 [PDF]
Richard J.L.F. Lemmers +29 more
openalex +1 more source
Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD [PDF]
Judit Balog +8 more
openalex +1 more source
Fibroblast cell line with inducible cassette exchange system- tool to study gain and loss of gene function [PDF]
We generated fibroblast cell line with single copy of targeting Cre/Lox cassette exchange. The cassette is targeted with circular plasmid P2lox/cre caring the gene of interest.
Bosnakovski, Darko
core
Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells [PDF]
Gregory J. Block +8 more
openalex +1 more source
MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy
V. Runfola +5 more
semanticscholar +1 more source
Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation
Sara T. Winokur
openalex +1 more source

